Clinical Trial Update: Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dolutegravir with 2 NRTIs in treatment-naïve HIV-2 infected subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Blueclinical, Ltd. | Conditions: HIV II Infection | Phase 2 | Status: COMPLETED